Dentol Oral Teething Pain Gel 7.5 %
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 4-aminobenzoïque, Ester d'éthyle | 7.5 Pour cent |
Non-medicinal ingredients
Sacharinate de sodium, PEG-400, Rouge FD&C N° 40, Glycérine, Acide sorbique, Saveur de cerise, Macrogol 3350
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Gel | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
| Enfants | minimum: 1 year | 1 Gel | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
| Nourrissons | minimum: 4 months ; maximum: 12 months | 1 Gel | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For temporary relief of sore gums due to teething in infants 4 months of age and older and children. For the temporary relief of occasional minor irritation or injury of the gums and for the temporary relief of pain due to minor dental procedures.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Avoid contact with eyes; if this happens, rinse thoroughly with water. If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use and consult a doctor. Keep out of reach of children. Stop use and consult a health-care practitioner if the following symptoms appear: weakness, confusion headache, difficulty breathing and/or pale, gray or blue colored skin as these may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use. Use with caution in children or consult a healthcare practitioner prior to use for children less than two years of age. Fever and nasal congestion are not symptoms of teething pain and may indicate infection. If these symptoms occur, consult a health care practitioner.
- Contre-indications
Do not use if allergic to benzocaine or any other ingredient in the product.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur. In such a case, discontinue use.
Product record
- Licence holder
- Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.
- NPN or DIN-HM
- 80065413
- Status
- Inactive licence
- Licence date
- 24 November 2015
- Revision date
- Not provided
- Form
- Gel gingivale
- Route of administration
- Parodontal
- Application type
- Officinale
Source
Official Health Canada record, licence 80065413
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Dentol Oral Teething Pain Gel 7.5 % (Pharmascience Inc. / Pendopharms, Division of Pharmascience Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80065413-dentol-oral-teething-pain-gel-7-5, updated 24 November 2015.